Teva Pharma (TEVA) Tops Q4 EPS by 5c, Revenues Beat; Offers FY21 EPS/Revenue Guidance
Go back to Teva Pharma (TEVA) Tops Q4 EPS by 5c, Revenues Beat; Offers FY21 EPS/Revenue Guidance| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 13.01 +0.13 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.88 | 52 Week High | $66.55 | |||
| Open | $12.94 | 52 Week Low | $37.82 | |||
| Day High | $13.03 | P/E | N/A | |||
| Day Low | $12.78 | EPS | $0.00 | |||
| Volume | 8,982,081 | |||||
